Alexander Manzella
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Alexander Manzella has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Toni Beninato
Department of Surgery, Rutgers Cancer Institute of New Jersey, Rutgers Robert Wood Johnson Medical School, 195 Little Albany St, New Brunswick, NJ, 08901, United States
5 shared publications - Amanda M. Laird
Department of Surgery Rutgers-Cancer Institute of New Jersey, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ https://twitter.com/amlaird
4 shared publications - Joshua C. Chao
Rutgers Robert Wood Johnson Med Sch, Dept Surg, POB 19, MEB 596, New Brunswick, NJ 08903 USA
3 shared publications Marin Kheng
Rutgers Robert Wood Johnson Med Sch, Rutgers Canc Inst New Jersey, New Brunswick, NJ USA
3 shared publications- Marin Kheng
Rutgers Robert Wood Johnson Med Sch, Dept Surg, POB 19, MEB 596, New Brunswick, NJ 08903 USA
2 shared publications Amanda M. Laird
Rutgers Robert Wood Johnson Medical School, Rutgers Cancer Institute of New Jersey, USA
1 shared publication
Latest Publications
- 1 August 2024
- Published by SAGE Publications in Thyroid®
- Vol. 34 (8) , 1007-1016
Reoperation Rates After Initial Thyroid Lobectomy for Patients with Thyroid Cancer: A National Cohort Study
Introduction The 2015 ATA guidelines recommended thyroid lobectomy (TL) as an alternative to total thyroidectomy (TT) for the surgical treatment of low-risk differentiated thyroid cancer. Increasing use of TL has since been reported despite concerns for an increased risk of disease recurrence and need for reoperation. This study sought to compare reoperation rates among patients who underwent initial TL or TT for malignancy, characterize trends at centers based on operative volume, and examine factors associated with reoperation. Methods We queried the Vizient Clinical Data Base for TL and TT performed pre-guideline change (pre-GC=2013-2015) and post-guideline change (post-GC=2016-2021). Reoperations included reoperative thyroid surgery (RTS) and neck dissection (ND); timing was defined as early (180 days), thought to indicate inadequacy of initial operative choice, or late (>180 days), suggesting disease recurrence. Results Of 65,627 patients, 31.8% underwent initial TL and 68.2% underwent initial TT; TL increased from 21.4% of total cases pre-GC to 37.0% post-GC (p<0.001). Among TL patients, early RTS declined from 33.9%-14.2% and ND declined from 0.8%-0.4% (p<0.001). Among TT patients, early RTS remained 0.2%, while ND increased from 0.4%-0.7% (p<0.001). TL-associated late RTS declined from 2.0%-1.7%, while ND increased from 0.6%-0.8% (p=0.17). In TT patients, both late RTS and ND increased, from 0.2%-0.3% (p=0.04) and 1.7%-2.1% (p<0.01), respectively. There was no difference in the late reoperation rate for TL compared to TT post-GC (+0.2%, p=0.18). TL volume grew annually by 12.5% [8.9%-16.2%] at high-volume centers and 8.3% [5.6%-11.1%] at low-volume centers. TL-associated reoperations at high-volume centers declined annually by 12.6% [5.6%-19.0%] and 10.8% [2.7%-18.1%] at low-volume centers. Uninsured status and more recent initial operation were associated with an increased risk of late reoperation (HR=1.84 [1.06-3.20] and HR=1.30 [1.24-1.36], respectively). The type of index operation performed, however, was not predictive of late reoperation. Conclusions The rate of early reoperations declined for thyroid lobectomy after the 2015 ATA guideline release but late reoperations remained unchanged despite a significant shift in practice patterns towards performing initial lobectomy. Patients appear to be receiving less aggressive, guideline-concordant care without a significant increase in the late reoperation rate for thyroid lobectomy compared to total thyroidectomy.
- 1 August 2024
- Published by SAGE Publications in Thyroid®
- Vol. 34 (8) , 1007-1016
Reoperation Rates After Initial Thyroid Lobectomy for Patients with Thyroid Cancer: A National Cohort Study
Introduction The 2015 ATA guidelines recommended thyroid lobectomy (TL) as an alternative to total thyroidectomy (TT) for the surgical treatment of low-risk differentiated thyroid cancer. Increasing use of TL has since been reported despite concerns for an increased risk of disease recurrence and need for reoperation. This study sought to compare reoperation rates among patients who underwent initial TL or TT for malignancy, characterize trends at centers based on operative volume, and examine factors associated with reoperation. Methods We queried the Vizient Clinical Data Base for TL and TT performed pre-guideline change (pre-GC=2013-2015) and post-guideline change (post-GC=2016-2021). Reoperations included reoperative thyroid surgery (RTS) and neck dissection (ND); timing was defined as early (180 days), thought to indicate inadequacy of initial operative choice, or late (>180 days), suggesting disease recurrence. Results Of 65,627 patients, 31.8% underwent initial TL and 68.2% underwent initial TT; TL increased from 21.4% of total cases pre-GC to 37.0% post-GC (p<0.001). Among TL patients, early RTS declined from 33.9%-14.2% and ND declined from 0.8%-0.4% (p<0.001). Among TT patients, early RTS remained 0.2%, while ND increased from 0.4%-0.7% (p<0.001). TL-associated late RTS declined from 2.0%-1.7%, while ND increased from 0.6%-0.8% (p=0.17). In TT patients, both late RTS and ND increased, from 0.2%-0.3% (p=0.04) and 1.7%-2.1% (p<0.01), respectively. There was no difference in the late reoperation rate for TL compared to TT post-GC (+0.2%, p=0.18). TL volume grew annually by 12.5% [8.9%-16.2%] at high-volume centers and 8.3% [5.6%-11.1%] at low-volume centers. TL-associated reoperations at high-volume centers declined annually by 12.6% [5.6%-19.0%] and 10.8% [2.7%-18.1%] at low-volume centers. Uninsured status and more recent initial operation were associated with an increased risk of late reoperation (HR=1.84 [1.06-3.20] and HR=1.30 [1.24-1.36], respectively). The type of index operation performed, however, was not predictive of late reoperation. Conclusions The rate of early reoperations declined for thyroid lobectomy after the 2015 ATA guideline release but late reoperations remained unchanged despite a significant shift in practice patterns towards performing initial lobectomy. Patients appear to be receiving less aggressive, guideline-concordant care without a significant increase in the late reoperation rate for thyroid lobectomy compared to total thyroidectomy.
- 19 August 2023
- Published by Elsevier in The American Journal of Surgery
- Vol. 228, 22-29
Effects of the COVID-19 pandemic on endocrine operations in the United States
- 19 August 2023
- Published by Elsevier in The American Journal of Surgery
- Vol. 228, 22-29
Effects of the COVID-19 pandemic on endocrine operations in the United States
- 25 October 2022
- Published by Elsevier in The American Journal of Surgery
- Vol. 225 (4) , 679-684
Association of Medicaid expansion of the Affordable Care Act with operations for benign endocrine surgical disease
- 25 October 2022
- Published by Elsevier in The American Journal of Surgery
- Vol. 225 (4) , 679-684
Association of Medicaid expansion of the Affordable Care Act with operations for benign endocrine surgical disease